SPL 1.02% 9.9¢ starpharma holdings limited

Clinical trial thoughts, page-23

  1. 3,506 Posts.
    lightbulb Created with Sketch. 836
    OMG @wingnut, cherry picking much? You must work for Starpharma.

    Yes, the article recommends that Nitric Oxide studies into virus reproduction in the body shouldn’t continue. But Viraleze has never been tested for virus reproduction in the body either!

    Importantly, (and as a direct and relevant comparison to Viraleze), the article in the link you provided goes on to say this about the Sanotize nasal spray:

    One small study (Starpharma’s was much smaller) found that they can reduce viral load by about 95% after 24 hours (*significantly better than Viraleze). A randomized-control study of over 300 people found that using nitric oxide nasal spray sped up clearance of the virus, potentially decreasing the time someone is contagious. And larger clinical trials for nitric oxide nasal sprays are still taking place.

    Last edited by sarge17: 31/01/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.9¢
Change
0.001(1.02%)
Mkt cap ! $41.39M
Open High Low Value Volume
9.8¢ 10.0¢ 9.8¢ $28.58K 288.8K

Buyers (Bids)

No. Vol. Price($)
1 59999 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 1252 1
View Market Depth
Last trade - 16.10pm 07/11/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.